Document Detail


Unmet needs in the treatment of anxiety disorders.
MedLine Citation:
PMID:  17065968     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
There are a number of unmet needs in the treatment of anxiety disorders including the need for more effective, rapidly acting, and better tolerated medications; early identification of nonresponse; effective treatments for refractory disorders; prevention of relapse; and promotion of resilience and long-lasting response. Rates of response to contemporary antidepressants and other anxiolytics are often less robust than might be hoped, and remission rates, which have until recently been infrequently measured, are even lower. A small number of mostly uncontrolled studies suggest a role for augmentation of initial therapy with a second modality in patients who do not fully remit to treatment. There also is a small but growing literature which suggests the use of novel anticonvulsants and atypical antipsychotics in the treatment of anxiety disorders should be further studied. However, a definitive place for these newer therapeutic strategies in the anxiety disorder treatment armamentarium awaits evidence from large, controlled studies.
Authors:
Mark H Pollack
Related Documents :
17682658 - Chronic insomnia as a risk factor for developing anxiety and depression.
17964368 - Delirium, depression, and other psychosocial and neurobehavioral issues in cardiovascul...
19560808 - Systematic review and meta-analysis of interventions relevant for young offenders with ...
19716988 - Anxiety and anxiety disorders in children and adolescents: developmental issues and imp...
3163318 - Fibromyalgia in the elderly: differential diagnosis and treatment.
18250958 - Reduced number of taste papillae in patients with eating disorders.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Psychopharmacology bulletin     Volume:  38 Suppl 1     ISSN:  0048-5764     ISO Abbreviation:  Psychopharmacol Bull     Publication Date:  2004  
Date Detail:
Created Date:  2006-10-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0101123     Medline TA:  Psychopharmacol Bull     Country:  United States    
Other Details:
Languages:  eng     Pagination:  31-7     Citation Subset:  IM    
Affiliation:
Harvard Medical School.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Late-life anxiety disorders.
Next Document:  Drug development for anxiety disorders: new roles for atypical antipsychotics.